Aleva Neurotherapeutics, a leading company developing next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson´s disease, announced that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research (up to $180,000).
Source: Startupticker.ch